Hat-Trick for baby brains: new monitor could spot injury sooner

NCT ID NCT02793999

Recruiting now Knowledge-focused Sponsor: Boston Children's Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, non-invasive device that measures oxygen levels in the brains of newborns at risk for brain injury. Researchers will compare readings from babies receiving cooling therapy, those with brain injury not getting cooling, and healthy newborns. The goal is to see if this device can help doctors better monitor brain health and guide treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Near-Infrared Spectroscopy (NIRS) device
What this could lead to: If successful, this could lead to a better bedside tool for monitoring brain health in newborns, helping doctors tailor treatments like cooling therapy.
What could go wrong: This is an early-stage study focused on measuring and comparing data, not testing a treatment. The device may not prove accurate or useful in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXIC-ISCHEMIC BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain hypoxia - ischemia perinatal asphyxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOXIC-ISCHEMIC BRAIN INJURY NEONATAL ENCEPHALOPATHY

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
NOT_YET_RECRUITING

Boston, Massachusetts, 02215, United States
Boston Children's Hospital
RECRUITING

Boston, Massachusetts, 02115, United States
Brigham and Women's Hospital
NOT_YET_RECRUITING

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.